{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T09:15:57Z","timestamp":1794129357215,"version":"4.8.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11894-025-00998-0","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T07:41:59Z","timestamp":1751010119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Guide Through the Tunnel: Updates in the Approach to Classification and Management of Perianal Fistulizing Crohn\u2019s Disease"],"prefix":"10.1007","volume":"27","author":[{"given":"WonKyung J.","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serre-Yu","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"issue":"11","key":"998_CR1","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nrgastro.2017.104","volume":"14","author":"J Panes","year":"2017","unstructured":"Panes J, Rimola J. Perianal fistulizing crohn\u2019s disease: pathogenesis, diagnosis and therapy. Nat Rev Gastroenterol Hepatol. 2017;14(11):652\u201364.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"998_CR2","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/ibd\/izab287","volume":"28","author":"L Tsai","year":"2022","unstructured":"Tsai L, McCurdy JD, Ma C, Jairath V, Singh S. Epidemiology and natural history of perianal crohn\u2019s disease: A systematic review and Meta-Analysis of Population-Based cohorts. Inflamm Bowel Dis. 2022;28(10):1477\u201384.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"998_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ibd\/izz104","volume":"26","author":"KT Park","year":"2020","unstructured":"Park KT, Ehrlich OG, Allen JI, Meadows P, Szigethy EM, Henrichsen K, et al. The cost of inflammatory bowel disease: an initiative from the crohn\u2019s & colitis foundation. Inflamm Bowel Dis. 2020;26(1):1\u201310.","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"998_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S2468-1253(23)00003-1","volume":"8","author":"J Burisch","year":"2023","unstructured":"Burisch J, Zhao M, Odes S, De Cruz P, Vermeire S, Bernstein CN, et al. The cost of inflammatory bowel disease in high-income settings: a lancet gastroenterology & hepatology commission. Lancet Gastroenterol Hepatol. 2023;8(5):458\u201392.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"998_CR5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.gastro.2003.08.024","volume":"125","author":"American Gastroenterological Association Clinical Practice C","year":"2003","unstructured":"American Gastroenterological Association Clinical Practice C. American gastroenterological association medical position statement: perianal crohn\u2019s disease. Gastroenterology. 2003;125(5):1503\u20137.","journal-title":"Gastroenterology"},{"issue":"1","key":"998_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/bjs.1800630102","volume":"63","author":"AG Parks","year":"1976","unstructured":"Parks AG, Gordon PH, Hardcastle JD. A classification of fistula-in-ano. Br J Surg. 1976;63(1):1\u201312.","journal-title":"Br J Surg"},{"issue":"3","key":"998_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1148\/radiographics.20.3.g00mc15623","volume":"20","author":"J Morris","year":"2000","unstructured":"Morris J, Spencer JA, Ambrose NS. MR imaging classification of perianal fistulas and its implications for patient management. Radiographics. 2000;20(3):623\u201335. discussion 35\u2013\u20097.","journal-title":"Radiographics"},{"key":"998_CR8","doi-asserted-by":"crossref","unstructured":"Zhou Z, Ouboter LF, Peeters K, Hawinkels L, Holman F, Pascutti MF et al. Crohn\u2019s disease-associated and cryptoglandular fistulas: Differences and similarities. J Clin Med. 2023;12(2).","DOI":"10.3390\/jcm12020466"},{"issue":"12","key":"998_CR9","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1111\/j.1572-0241.2003.08716.x","volume":"98","author":"G Coremans","year":"2003","unstructured":"Coremans G, Dockx S, Wyndaele J, Hendrickx A. Do anal fistulas in crohn\u2019s disease behave differently and defy goodsall\u2019s rule more frequently than fistulas that are cryptoglandular in origin? Am J Gastroenterol. 2003;98(12):2732\u20135.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"998_CR10","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1053\/j.gastro.2019.07.027","volume":"157","author":"P Hindryckx","year":"2019","unstructured":"Hindryckx P, Jairath V, Zou G, Feagan BG, Sandborn WJ, Stoker J, et al. Development and validation of a magnetic resonance index for assessing fistulas in patients with crohn\u2019s disease. Gastroenterology. 2019;157(5):1233\u201344. e5.","journal-title":"Gastroenterology"},{"issue":"3","key":"998_CR11","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1007\/s00330-024-11029-3","volume":"35","author":"KJ Beek","year":"2025","unstructured":"Beek KJ, Mulders LGM, van Rijn KL, Horsthuis K, Tielbeek JAW, Buskens CJ, et al. External validation of the MAGNIFI-CD index in patients with complex perianal fistulising crohn\u2019s disease. Eur Radiol. 2025;35(3):1428\u201339.","journal-title":"Eur Radiol"},{"issue":"5","key":"998_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/ibd\/izab147","volume":"28","author":"S Choshen","year":"2022","unstructured":"Choshen S, Turner D, Pratt LT, Precel R, Greer ML, Castro DA, et al. Development and validation of a pediatric MRI-Based perianal Crohn disease (PEMPAC) Index-A report from the ImageKids study. Inflamm Bowel Dis. 2022;28(5):700\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"998_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/ibd\/izad134","volume":"30","author":"E Crowley","year":"2024","unstructured":"Crowley E, Ma C, Guizzetti L, Zou G, Lewindon PJ, Gee MS, et al. Recommendations for standardizing MRI-based evaluation of perianal fistulizing disease activity in pediatric crohn\u2019s disease clinical trials. Inflamm Bowel Dis. 2024;30(3):357\u201369.","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"998_CR14","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.cgh.2023.12.006","volume":"22","author":"JD McCurdy","year":"2024","unstructured":"McCurdy JD, Munir J, Parlow S, Reid J, Yanofsky R, Alenezi T, et al. Development of an MRI-Based prediction model for Anti-TNF treatment failure in perianal crohn\u2019s disease: A multicenter study. Clin Gastroenterol Hepatol. 2024;22(5):1058\u201366. e2.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"998_CR15","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/ecco-jcc\/jjab168","volume":"16","author":"KL van Rijn","year":"2022","unstructured":"van Rijn KL, Meima-van Praag EM, Bossuyt PM, D\u2019Haens GR, Gecse KB, Horsthuis K, et al. Fibrosis and MAGNIFI-CD activity index at magnetic resonance imaging to predict treatment outcome in perianal fistulizing crohn\u2019s disease patients. J Crohns Colitis. 2022;16(5):708\u201316.","journal-title":"J Crohns Colitis"},{"issue":"6","key":"998_CR16","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1093\/ecco-jcc\/jjad214","volume":"18","author":"SK Vuyyuru","year":"2024","unstructured":"Vuyyuru SK, Solitano V, Singh S, Hanzel J, Macdonald JK, Danese S, et al. Scoring indices for perianal fistulising crohn\u2019s disease: A systematic review. J Crohns Colitis. 2024;18(6):836\u201350.","journal-title":"J Crohns Colitis"},{"issue":"9","key":"998_CR17","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1093\/ecco-jcc\/jjae056","volume":"18","author":"MK Schroeder","year":"2024","unstructured":"Schroeder MK, Abushamma S, George AT, Ravella B, Hickman J, Elumalai A, et al. TOpCLASS expert consensus classification of perianal fistulising crohn\u2019s disease: A Real-world application in a serial fistula MRI cohort. J Crohn\u2019s Colitis. 2024;18(9):1430\u20139.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"6","key":"998_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S2468-1253(22)00007-3","volume":"7","author":"J Geldof","year":"2022","unstructured":"Geldof J, Iqbal N, LeBlanc JF, Anandabaskaran S, Sawyer R, Buskens C, et al. Classifying perianal fistulising crohn\u2019s disease: an expert consensus to guide decision-making in daily practice and clinical trials. Lancet Gastroenterol Hepatol. 2022;7(6):576\u201384.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"998_CR19","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJMoa030815","volume":"350","author":"BE Sands","year":"2004","unstructured":"Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, et al. Infliximab maintenance therapy for fistulizing crohn\u2019s disease. N Engl J Med. 2004;350(9):876\u201385.","journal-title":"N Engl J Med"},{"issue":"4","key":"998_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/gutjnl-2024-333280","volume":"74","author":"J Adler","year":"2025","unstructured":"Adler J, Gadepalli S, Rahman M, Kim S. Early tumour necrosis factor antagonist treatment prevents perianal fistula development in children with crohn\u2019s disease: post hoc analysis of the RISK study. Gut. 2025;74(4):539\u201346.","journal-title":"Gut"},{"key":"998_CR21","doi-asserted-by":"crossref","unstructured":"McCurdy J, Munir J, Parlow S, Sambhi G, Reid J, Yanofsky R et al. The impact of setons on perianal fistula outcomes in patients With crohn\u2019s disease treated with anti-TNF therapy: a multicentre study. Aliment Pharmacol Ther. 2025;n\/a(n\/a).","DOI":"10.1111\/apt.70081"},{"issue":"8","key":"998_CR22","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/ecco-jcc\/jjaa004","volume":"14","author":"KA Wasmann","year":"2020","unstructured":"Wasmann KA, de Groof EJ, Stellingwerf ME, D\u2019Haens GR, Ponsioen CY, Gecse KB, et al. Treatment of perianal fistulas in crohn\u2019s disease, Seton versus Anti-TNF versus surgical closure following Anti-TNF [PISA]: A randomised controlled trial. J Crohns Colitis. 2020;14(8):1049\u201356.","journal-title":"J Crohns Colitis"},{"issue":"23","key":"998_CR23","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.3748\/wjg.v28.i23.2597","volume":"28","author":"B Gu","year":"2022","unstructured":"Gu B, Venkatesh K, Williams AJ, Ng W, Corte C, Gholamrezaei A, et al. Higher Infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal crohn\u2019s disease. World J Gastroenterol. 2022;28(23):2597\u2013608.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"998_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/00365521.2019.1600014","volume":"54","author":"AS Strik","year":"2019","unstructured":"Strik AS, Lowenberg M, Buskens CJ, K BG, C IP, Bemelman WA, et al. Higher anti-TNF serum levels are associated with perianal fistula closure in crohn\u2019s disease patients. Scand J Gastroenterol. 2019;54(4):453\u20138.","journal-title":"Scand J Gastroenterol"},{"key":"998_CR25","doi-asserted-by":"crossref","unstructured":"Zulqarnain M, Deepak P, Yarur AJ. Therapeutic drug monitoring in perianal fistulizing Crohn\u2019s disease. J Clin Med. 2022;11(7).","DOI":"10.3390\/jcm11071813"},{"issue":"3","key":"998_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/ibd\/izac103","volume":"29","author":"M Shehab","year":"2023","unstructured":"Shehab M, Alrashed F, Heron V, Restellini S, Bessissow T. Comparative efficacy of biologic therapies for inducing response and remission in fistulizing crohn\u2019s disease: systematic review and network Meta-Analysis of randomized controlled trials. Inflamm Bowel Dis. 2023;29(3):367\u201375.","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"998_CR27","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/MEG.0000000000002552","volume":"35","author":"JK Chahal","year":"2023","unstructured":"Chahal JK, Sriranganathan D, Poo S, Lo SW, Kashkooli S, Garg M, et al. Network meta-analysis: efficacy and safety of treatments for fistulising crohn\u2019s disease. Eur J Gastroenterol Hepatol. 2023;35(7):702\u201310.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"15","key":"998_CR28","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","volume":"362","author":"JF Colombel","year":"2010","unstructured":"Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, et al. Infliximab, azathioprine, or combination therapy for crohn\u2019s disease. N Engl J Med. 2010;362(15):1383\u201395.","journal-title":"N Engl J Med"},{"issue":"1","key":"998_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/00365521.2020.1854848","volume":"56","author":"M Attauabi","year":"2021","unstructured":"Attauabi M, Burisch J, Seidelin JB. Efficacy of ustekinumab for active perianal fistulizing crohn\u2019s disease: a systematic review and meta-analysis of the current literature. Scand J Gastroenterol. 2021;56(1):53\u20138.","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"998_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/ecco-jcc\/jjad185","volume":"18","author":"SK Vuyyuru","year":"2024","unstructured":"Vuyyuru SK, Solitano V, Narula N, Lee MJ, MacDonald JK, McCurdy JD, et al. Pharmacological therapies for the management of fistulizing crohn\u2019s disease: A systematic review and Meta-Analysis. J Crohns Colitis. 2024;18(4):589\u2013603.","journal-title":"J Crohns Colitis"},{"issue":"11","key":"998_CR31","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.14309\/ajg.0000000000000810","volume":"115","author":"C Chapuis-Biron","year":"2020","unstructured":"Chapuis-Biron C, Kirchgesner J, Pariente B, Bouhnik Y, Amiot A, Viennot S, et al. Ustekinumab for perianal crohn\u2019s disease: the biolap multicenter study from the GETAID. Am J Gastroenterol. 2020;115(11):1812\u201320.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"998_CR32","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/apt.15665","volume":"51","author":"C Chapuis-Biron","year":"2020","unstructured":"Chapuis-Biron C, Bourrier A, Nachury M, Nancey S, Bouhnik Y, Serrero M, et al. Vedolizumab for perianal crohn\u2019s disease: a multicentre cohort study in 151 patients. Aliment Pharmacol Ther. 2020;51(7):719\u201327.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"998_CR33","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cgh.2021.09.028","volume":"20","author":"DA Schwartz","year":"2022","unstructured":"Schwartz DA, Peyrin-Biroulet L, Lasch K, Adsul S, Danese S. Efficacy and safety of 2 Vedolizumab intravenous regimens for perianal fistulizing crohn\u2019s disease: ENTERPRISE study. Clin Gastroenterol Hepatol. 2022;20(5):1059\u2013e679.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"998_CR34","doi-asserted-by":"crossref","unstructured":"Colombel JF, Lacerda AP, Irving PM, Panaccione R, Reinisch W, Rieder F, et al. Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn\u2019s Disease: A Post Hoc Analysis of 3 Phase 3 Trials. Clin Gastroenterol Hepatol; 2024.","DOI":"10.1016\/j.cgh.2024.08.032"},{"issue":"7","key":"998_CR35","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1053\/j.gastro.2021.04.022","volume":"160","author":"JD Feuerstein","year":"2021","unstructured":"Feuerstein JD, Ho EY, Shmidt E, Singh H, Falck-Ytter Y, Sultan S, et al. AGA clinical practice guidelines on the medical management of moderate to severe luminal and perianal fistulizing crohn\u2019s disease. Gastroenterology. 2021;160(7):2496\u2013508.","journal-title":"Gastroenterology"},{"issue":"10","key":"998_CR36","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1093\/ecco-jcc\/jjae091","volume":"18","author":"H Gordon","year":"2024","unstructured":"Gordon H, Minozzi S, Kopylov U, Verstockt B, Chaparro M, Buskens C, et al. ECCO guidelines on therapeutics in crohn\u2019s disease: medical treatment. J Crohns Colitis. 2024;18(10):1531\u201355.","journal-title":"J Crohns Colitis"},{"key":"998_CR37","unstructured":"Hanna LN, Anandabaskaran S, Iqbal N, Geldof J, LeBlanc JF, Dige A, et al. Perianal Fistulizing Crohn\u2019s Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized Care. Clin Gastroenterol Hepatol; 2024."},{"issue":"11\u201312","key":"998_CR38","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1046\/j.1365-2036.2003.01793.x","volume":"18","author":"C Dejaco","year":"2003","unstructured":"Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W. Antibiotics and azathioprine for the treatment of perianal fistulas in crohn\u2019s disease. Aliment Pharmacol Ther. 2003;18(11\u201312):1113\u201320.","journal-title":"Aliment Pharmacol Ther"},{"key":"998_CR39","unstructured":"Gold SL, Cohen-Mekelburg S, Schneider Y, Steinlauf A. Perianal fistulas in patients with crohn\u2019s disease, part 1: current medical management. Gastroenterol Hepatol (N Y). 2018;14(8):470\u201381."},{"issue":"2","key":"998_CR40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/gutjnl-2013-304488","volume":"63","author":"P Dewint","year":"2014","unstructured":"Dewint P, Hansen BE, Verhey E, Oldenburg B, Hommes DW, Pierik M, et al. Adalimumab combined with Ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in crohn\u2019s disease: a randomised, double-blind, placebo controlled trial (ADAFI). Gut. 2014;63(2):292\u20139.","journal-title":"Gut"},{"issue":"11\u201312","key":"998_CR41","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/j.1365-2036.2004.02247.x","volume":"20","author":"RL West","year":"2004","unstructured":"West RL, van der Woude CJ, Hansen BE, Felt-Bersma RJ, van Tilburg AJ, Drapers JA, et al. Clinical and endosonographic effect of Ciprofloxacin on the treatment of perianal fistulae in crohn\u2019s disease with infliximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2004;20(11\u201312):1329\u201336.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"998_CR42","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S2468-1253(22)00088-7","volume":"7","author":"EM Meima-van Praag","year":"2022","unstructured":"Meima-van Praag EM, van Rijn KL, Wasmann K, Snijder HJ, Stoker J, D\u2019Haens GR, et al. Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in crohn\u2019s disease (PISA-II): a patient preference randomised trial. Lancet Gastroenterol Hepatol. 2022;7(7):617\u201326.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"998_CR43","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/apt.18466","volume":"61","author":"JD McCurdy","year":"2025","unstructured":"McCurdy JD, Hartley I, Behrenbruch C, Hart A, Tozer P, Ding NS. Management of perianal fistulizing crohn\u2019s disease according to principles of wound repair. Aliment Pharmacol Ther. 2025;61(4):600\u201313.","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"998_CR44","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.cgh.2012.12.042","volume":"11","author":"G Bouguen","year":"2013","unstructured":"Bouguen G, Siproudhis L, Gizard E, Wallenhorst T, Billioud V, Bretagne JF, et al. Long-term outcome of perianal fistulizing crohn\u2019s disease treated with Infliximab. Clin Gastroenterol Hepatol. 2013;11(8):975\u201381. e1-4.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"97","key":"998_CR45","first-page":"3","volume":"57","author":"S Tanaka","year":"2010","unstructured":"Tanaka S, Matsuo K, Sasaki T, Nakano M, Sakai K, Beppu R, et al. Clinical advantages of combined Seton placement and Infliximab maintenance therapy for perianal fistulizing crohn\u2019s disease: when and how were the Seton drains removed? Hepatogastroenterology. 2010;57(97):3\u20137.","journal-title":"Hepatogastroenterology"},{"issue":"2","key":"998_CR46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00384-014-2072-y","volume":"30","author":"KW Gottgens","year":"2015","unstructured":"Gottgens KW, Janssen PT, Heemskerk J, van Dielen FM, Konsten JL, Lettinga T, et al. Long-term outcome of low perianal fistulas treated by fistulotomy: a multicenter study. Int J Colorectal Dis. 2015;30(2):213\u20139.","journal-title":"Int J Colorectal Dis"},{"issue":"5","key":"998_CR47","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00384-017-2779-7","volume":"32","author":"Z Balciscueta","year":"2017","unstructured":"Balciscueta Z, Uribe N, Balciscueta I, Andreu-Ballester JC, Garcia-Granero E. Rectal advancement flap for the treatment of complex cryptoglandular anal fistulas: a systematic review and meta-analysis. Int J Colorectal Dis. 2017;32(5):599\u2013609.","journal-title":"Int J Colorectal Dis"},{"issue":"5","key":"998_CR48","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/codi.12224","volume":"15","author":"NA Yassin","year":"2013","unstructured":"Yassin NA, Hammond TM, Lunniss PJ, Phillips RK. Ligation of the intersphincteric fistula tract in the management of anal fistula. A systematic review. Colorectal Dis. 2013;15(5):527\u201335.","journal-title":"Colorectal Dis"},{"issue":"2","key":"998_CR49","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.surg.2023.04.004","volume":"174","author":"SH Emile","year":"2023","unstructured":"Emile SH, Garoufalia Z, Aeschbacher P, Horesh N, Gefen R, Wexner SD. Endorectal advancement flap compared to ligation of inter-sphincteric fistula tract in the treatment of complex anal fistulas: A meta-analysis of randomized clinical trials. Surgery. 2023;174(2):172\u20139.","journal-title":"Surgery"},{"issue":"10","key":"998_CR50","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10151-022-02614-z","volume":"26","author":"Z Tian","year":"2022","unstructured":"Tian Z, Li YL, Nan SJ, Xiu WC, Wang YQ. Video-assisted anal fistula treatment for complex anorectal fistulas in adults: a systematic review and meta-analysis. Tech Coloproctol. 2022;26(10):783\u201395.","journal-title":"Tech Coloproctol"},{"issue":"10","key":"998_CR51","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10151-022-02682-1","volume":"26","author":"D Cao","year":"2022","unstructured":"Cao D, Li W, Ji Y, Wang X, Cui Z. Efficacy and safety of filac for perianal fistulizing crohn\u2019s disease: a systematic review and meta-analysis. Tech Coloproctol. 2022;26(10):775\u201381.","journal-title":"Tech Coloproctol"},{"issue":"5","key":"998_CR52","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/DCR.0000000000001093","volume":"61","author":"AL Lightner","year":"2018","unstructured":"Lightner AL, Wang Z, Zubair AC, Dozois EJ. A systematic review and Meta-analysis of mesenchymal stem cell injections for the treatment of perianal crohn\u2019s disease: progress made and future directions. Dis Colon Rectum. 2018;61(5):629\u201340.","journal-title":"Dis Colon Rectum"},{"key":"998_CR53","doi-asserted-by":"crossref","unstructured":"Taxonera C, Garcia-Brenes MA, Olivares D, Lopez-Garcia ON, Zapater R, Alba C. Darvadstrocel for complex perianal fistulas in Crohn\u2019s disease: a systematic review and meta-analysis. United Eur Gastroenterol J. 2025;13(3):416\u20136.","DOI":"10.1002\/ueg2.12673"},{"issue":"4","key":"998_CR54","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s40259-024-00661-6","volume":"38","author":"AL Lightner","year":"2024","unstructured":"Lightner AL, Irving PM, Lord GM, Betancourt A. Stem cells and stem Cell-Derived factors for the treatment of inflammatory bowel disease with a particular focus on perianal fistulizing disease: A minireview on future perspectives. BioDrugs. 2024;38(4):527\u201339.","journal-title":"BioDrugs"},{"issue":"5","key":"998_CR55","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/DCR.0000000000002325","volume":"65","author":"D Garcia-Olmo","year":"2022","unstructured":"Garcia-Olmo D, Gilaberte I, Binek M, AJL DH, Lindner D, Selvaggi F, et al. Follow-up study to evaluate the Long-term safety and efficacy of Darvadstrocel (Mesenchymal stem cell Treatment) in patients with perianal fistulizing crohn\u2019s disease: ADMIRE-CD phase 3 randomized controlled trial. Dis Colon Rectum. 2022;65(5):713\u201320.","journal-title":"Dis Colon Rectum"},{"issue":"Supplement1","key":"998_CR56","doi-asserted-by":"publisher","first-page":"i34","DOI":"10.1093\/ecco-jcc\/jjad212.0018","volume":"18","author":"Z Serclova","year":"2024","unstructured":"Serclova Z, Garcia-Olmo D, Chen ST, Wexner S, Pan\u00e9s J, Wu C, et al. OP18 efficacy and safety of Darvadstrocel treatment in patients with complex perianal fistulas and crohn\u2019s disease: results from the global ADMIRE-CD II phase 3 study. J Crohn\u2019s Colitis. 2024;18(Supplement1):i34\u20135.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"2","key":"998_CR57","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/apt.18408","volume":"61","author":"JD McCurdy","year":"2025","unstructured":"McCurdy JD, Wong SY. Editorial: mesenchymal stem cell therapy for perianal fistulising crohn\u2019s Disease-Effective or hype?? Aliment Pharmacol Ther. 2025;61(2):386\u20137.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"998_CR58","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ueg2.12189","volume":"10","author":"CA Lansdorp","year":"2022","unstructured":"Lansdorp CA, Buskens CJ, Gecse KB, Lowenberg M, Stoker J, Bemelman WA, et al. Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with crohn\u2019s disease: results of the HOT-TOPIC trial after 1-year follow-up. United Eur Gastroenterol J. 2022;10(2):160\u20138.","journal-title":"United Eur Gastroenterol J"},{"issue":"4","key":"998_CR59","doi-asserted-by":"publisher","first-page":"FSO77","DOI":"10.4155\/fso.15.77","volume":"1","author":"G Agrawal","year":"2015","unstructured":"Agrawal G, Borody T, Turner R, Leis S, Campbell J. Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing crohn\u2019s disease. Future Sci OA. 2015;1(4):FSO77.","journal-title":"Future Sci OA"},{"issue":"Suppl 1","key":"998_CR60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1590\/S0102-86502016001300005","volume":"31","author":"MR Feitosa","year":"2016","unstructured":"Feitosa MR, Feres Filho O, Tamaki CM, Perazzoli C, Bernardes MV, Parra RS, et al. Adjunctive hyperbaric oxygen therapy promotes successful healing in patients with refractory crohn\u2019s disease. Acta Cir Bras. 2016;31(Suppl 1):19\u201323.","journal-title":"Acta Cir Bras"},{"issue":"2","key":"998_CR61","doi-asserted-by":"publisher","first-page":"e17289","DOI":"10.1111\/codi.17289","volume":"27","author":"MAJ Becker","year":"2025","unstructured":"Becker MAJ, Pronk AJM, Gecse K, Hompes R, Bemelman WA, Buskens CJ. Long-term outcomes of \u2018temporary\u2019 defunctioning in patients with severe perianal crohn\u2019s disease. Colorectal Dis. 2025;27(2):e17289.","journal-title":"Colorectal Dis"},{"issue":"3","key":"998_CR62","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/ibd\/izac099","volume":"29","author":"G Kassim","year":"2023","unstructured":"Kassim G, Yzet C, Nair N, Debebe A, Rendon A, Colombel JF, et al. Long-Term outcomes of the excluded rectum in crohn\u2019s disease: A multicenter international study. Inflamm Bowel Dis. 2023;29(3):417\u201322.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"998_CR63","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/ecco-jcc\/jjad159","volume":"18","author":"M Jew","year":"2024","unstructured":"Jew M, Meserve J, Eisenstein S, Jairath V, McCurdy J, Singh S. Temporary faecal diversion for refractory perianal and\/or distal colonic crohn\u2019s disease in the biologic era: an updated systematic review with Meta-analysis. J Crohns Colitis. 2024;18(3):375\u201391.","journal-title":"J Crohns Colitis"},{"key":"998_CR64","doi-asserted-by":"crossref","unstructured":"Alves Martins BA, Villar MT, Ferreira LVG, Ramos de Carvalho B, Avellaneda N, de Sousa JB. Long-term complications of proctectomy for refractory perianal Crohn\u2019s Disease: A Narrative review. J Clin Med. 2025;14(8).","DOI":"10.3390\/jcm14082802"},{"key":"998_CR65","doi-asserted-by":"crossref","unstructured":"Alipouriani A, Erozkan K, Schabl L, Sancheti H, Sebastian S, Wong SY, et al. TOpClass class 4 Perineal Crohn\u2019s disease: a systematic review and meta-analysis of perineal wound complication after proctectomy in Crohn\u2019s patients. Inflamm Bowel Dis. 2025;31(4):1150\u20137.","DOI":"10.1093\/ibd\/izae198"},{"issue":"3","key":"998_CR66","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/codi.12500","volume":"16","author":"XH Chan","year":"2014","unstructured":"Chan XH, Koh CE, Glover M, Bryson P, Travis SP, Mortensen NJ. Healing under pressure: hyperbaric oxygen and myocutaneous flap repair for extreme persistent perineal sinus after proctectomy for inflammatory bowel disease. Colorectal Dis. 2014;16(3):186\u201390.","journal-title":"Colorectal Dis"},{"issue":"7","key":"998_CR67","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1177\/2050640620934915","volume":"8","author":"CA Lansdorp","year":"2020","unstructured":"Lansdorp CA, Buskens CJ, Gecse KB, D\u2019Haens GR, Van Hulst RA. Wound healing of metastatic perineal crohn\u2019s disease using hyperbaric oxygen therapy: A case series. United Eur Gastroenterol J. 2020;8(7):820\u20137.","journal-title":"United Eur Gastroenterol J"},{"issue":"12","key":"998_CR68","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1111\/apt.70094","volume":"61","author":"E Anand","year":"2025","unstructured":"Anand E, Tozer P, Editorial. Seton use in perianal fistulising crohn\u2019s disease. Aliment Pharmacol Ther. 2025;61(12):1957\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"998_CR69","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/apt.13356","volume":"42","author":"S Singh","year":"2015","unstructured":"Singh S, Ding NS, Mathis KL, Dulai PS, Farrell AM, Pemberton JH, et al. Systematic review with meta-analysis: faecal diversion for management of perianal crohn\u2019s disease. Aliment Pharmacol Ther. 2015;42(7):783\u201392.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"998_CR70","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11605-006-0029-3","volume":"11","author":"MH Mueller","year":"2007","unstructured":"Mueller MH, Geis M, Glatzle J, Kasparek M, Meile T, Jehle EC, et al. Risk of fecal diversion in complicated perianal crohn\u2019s disease. J Gastrointest Surg. 2007;11(4):529\u201337.","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"998_CR71","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/ibd\/izab086","volume":"28","author":"JD McCurdy","year":"2022","unstructured":"McCurdy JD, Reid J, Yanofsky R, Sinnathamby V, Medawar E, Williams L, et al. Fecal diversion for perianal Crohn disease in the era of biologic therapies: A multicenter study. Inflamm Bowel Dis. 2022;28(2):226\u201333.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"998_CR72","first-page":"466","volume":"36","author":"S Naffouj","year":"2023","unstructured":"Naffouj S, Marrero-Rivera GE, Nordenstam J, Amber KT, Trivedi I. Cutaneous crohn\u2019s disease after proctocolectomy for medically refractory colonic crohn\u2019s disease: a case series and review of the literature. Ann Gastroenterol. 2023;36(4):466\u201376.","journal-title":"Ann Gastroenterol"},{"issue":"4","key":"998_CR73","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1055\/s-2007-991032","volume":"20","author":"JC Genua","year":"2007","unstructured":"Genua JC, Vivas DA. Management of nonhealing perineal wounds. Clin Colon Rectal Surg. 2007;20(4):322\u20138.","journal-title":"Clin Colon Rectal Surg"},{"issue":"10","key":"998_CR74","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00384-014-1935-6","volume":"29","author":"G Maconi","year":"2014","unstructured":"Maconi G, Gridavilla D, Vigano C, Sciurti R, Asthana AK, Furfaro F, et al. Perianal disease is associated with psychiatric co-morbidity in crohn\u2019s disease in remission. Int J Colorectal Dis. 2014;29(10):1285\u201390.","journal-title":"Int J Colorectal Dis"},{"key":"998_CR75","doi-asserted-by":"crossref","unstructured":"Wong SY, Rowan C, Brockmans ED, Law CCY, Giselbrecht E, Ang C, et al. Perianal fistulizing Crohn\u2019s disease-associated anorectal and fistula cancers: systematic review and expert consensus. Clin Gastroenterol Hepatol. 2025;23(6):927\u2013945.e2.","DOI":"10.1016\/j.cgh.2024.05.029"},{"issue":"4","key":"998_CR76","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s11605-010-1402-9","volume":"15","author":"MG Laukoetter","year":"2011","unstructured":"Laukoetter MG, Mennigen R, Hannig CM, Osada N, Rijcken E, Vowinkel T, et al. Intestinal cancer risk in crohn\u2019s disease: a meta-analysis. J Gastrointest Surg. 2011;15(4):576\u201383.","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"998_CR77","doi-asserted-by":"publisher","first-page":"e484","DOI":"10.1016\/j.cgh.2021.04.007","volume":"20","author":"O Atia","year":"2022","unstructured":"Atia O, Asayag N, Focht G, Lujan R, Ledder O, Greenfeld S, et al. Perianal crohn\u2019s disease is associated with poor disease outcome: A nationwide study from the EpiIIRN cohort. Clin Gastroenterol Hepatol. 2022;20(3):e484\u201395.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"998_CR78","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/DCR.0000000000000700","volume":"59","author":"C Shwaartz","year":"2016","unstructured":"Shwaartz C, Munger JA, Deliz JR, Bornstein JE, Gorfine SR, Chessin DB, et al. Fistula-Associated anorectal Cancer in the setting of crohn\u2019s disease. Dis Colon Rectum. 2016;59(12):1168\u201373.","journal-title":"Dis Colon Rectum"},{"key":"998_CR79","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jpsychores.2016.06.001","volume":"87","author":"R Neuendorf","year":"2016","unstructured":"Neuendorf R, Harding A, Stello N, Hanes D, Wahbeh H. Depression and anxiety in patients with inflammatory bowel disease: A systematic review. J Psychosom Res. 2016;87:70\u201380.","journal-title":"J Psychosom Res"},{"issue":"Supplement1","key":"998_CR80","doi-asserted-by":"publisher","first-page":"i2311","DOI":"10.1093\/ecco-jcc\/jjae190.1455","volume":"19","author":"B Gu","year":"2025","unstructured":"Gu B, Su WK, Nano D, Wilson W, Iliescu S, Lynch K, et al. P1281 active perianal fistulising crohn\u2019s disease is associated with a higher burden of psychological distress, depression, anxiety, stress and opioid use. J Crohn\u2019s Colitis. 2025;19(Supplement1):i2311\u20132.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"3","key":"998_CR81","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1463-1318.2011.02613.x","volume":"14","author":"S Mahadev","year":"2012","unstructured":"Mahadev S, Young JM, Selby W, Solomon MJ. Self-reported depressive symptoms and suicidal feelings in perianal crohn\u2019s disease. Colorectal Dis. 2012;14(3):331\u20135.","journal-title":"Colorectal Dis"},{"issue":"2","key":"998_CR82","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/ibd\/izz051","volume":"26","author":"S Laureti","year":"2020","unstructured":"Laureti S, Gionchetti P, Cappelli A, Vittori L, Contedini F, Rizzello F, et al. Refractory complex crohn\u2019s perianal fistulas: A role for autologous microfragmented adipose tissue injection. Inflamm Bowel Dis. 2020;26(2):321\u201330.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-00998-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-025-00998-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-00998-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:02:01Z","timestamp":1772578921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-025-00998-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["998"],"URL":"https:\/\/doi.org\/10.1007\/s11894-025-00998-0","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"19 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author SYW reports research contract with Takeda\/Trinetx; advisory board - Bristol Myers Squibb; and support - Eli Lilly and Company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"46"}}